abbott Xience Xpedition stent
Feature

Abbott announced that the Xience Xpedition everolimus-eluting coronary stent system received U.S. Food and Drug Administration (FDA) approval and is launching immediately in the United States, providing physicians with a next-generation technology with the largest size matrix in the U.S. market.

Home January 03, 2013
Home
Feature

The Medical Imaging and Technology Alliance (MITA) said that failure to delay the new medical device excise tax, along with Medicare cuts for imaging and radiation therapy services passed by Congress as part of the “fiscal cliff” package, will hinder patients’ access to early disease detection and therapy services and threaten American medical technology jobs.

Home January 02, 2013
Home
News

Siemens Healthcare recently received clearance from the U.S. Food and Drug Administration (FDA) for syngo Aortic ValveGuide, an integrated image processing software that helps cardiologists and cardiac surgeons prepare and perform transcatheter aortic valve replacement (TAVR). The syngo Aortic ValveGuide automatically reconstructs a 3-D representation of the aortic root from cross-sectional images acquired with the angiography system and provides the best projection angle for the valve replacement. The software selects anatomical landmarks and overlays the 3-D image with 2-D images acquired during live fluoroscopy, enabling the physician to obtain real-time 3-D guidance in the patient’s body while navigating the new valve to its intended location. This groundbreaking software, which is now available to customers, reflects the spirit of Siemens Healthcare’s Agenda 2013 — a recently announced two-year initiative designed in part to strengthen the Healthcare Sector's innovative power and competitiveness.

Home January 02, 2013
Home
News

Philips Royal Electronics and Unfors RaySafe AB announced the signing of a Joint Development Agreement that will see the development of the next generation Philips DoseAware system, with the aim of offering seamless access and communication between Philips DoseAware and Philips Allura interventional X-ray systems.

Home January 02, 2013
Home
News

At RSNA 2012 Montage Healthcare Solutions and Radimetrics demonstrated the benefits of correlating dose information with Montage clinical report search results.

Home January 02, 2013
Home
News

St. Jude Medical Inc. (announced European CE mark approval of the Assura portfolio of implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds). The Assura family of devices, featuring Shockguard technology has three new algorithms that help protect patients against inappropriate shocks while providing the highest amount of delivered energy. These improvements are projected to reduce inappropriate therapy by 74 percent, allowing for more effective therapy. Products currently available in Europe include the Quadra Assura CRT-D, Unify Assura CRT-D and Fortify Assura ICD.

Home December 31, 2012
Home
MRI 2012: Broadening Your Field of View KLS MRI Systems
Feature

The introduction of new technology into the magnetic resonance imaging (MRI) landscape has changed the face of the market segment over the last year. Although MRI satisfaction scores tend to cluster together, the differences are in the details, according to recent findings from healthcare technology research firm KLAS in its report MRI 2012: Broadening Your Field of View.

Home December 31, 2012
Home
SCAI Ad Hoc PCI Stenting Cath Lab Clinical Trial
Feature

When tests reveal that a patient’s heart artery is blocked and blood flow to the heart is restricted, should the doctor fix it with a stent or stop the test and discuss treatment options with the patient? Recommendations published by the Society for Cardiovascular Angiography and Interventions (SCAI) provide new guidance on when physicians should move forward immediately to open a blocked artery versus when to stop the test for further discussion with the patient or consultation with a heart surgeon.

Home December 31, 2012
Home
Technology

RamSoft announced its partnership with Digisonics to offer integrated, vendor-neutral cardiac post-processing and structured reporting for all cardiovascular modalities. Digisonics was recently named Best in KLAS for the Cardiology market segment for the fifth consecutive year.

Home December 31, 2012
Home
News

According to Millennium Research Group (MRG), approximately 80 percent of transcatheter aortic valve replacement (TAVR) procedures are being performed on high-risk patients who are ineligible for surgical heart valve replacement. New clinical evidence that supports TAVR in treatment of intermediate and high-risk operable patients has led to expanded reimbursement for a new patient base for the procedure.

Home December 31, 2012
Home
News

Merge Healthcare Inc. announced that Merge Hemo has been named the "Category Leader" in the "2012 Best in KLAS Awards: Software & Services" report for Cardiology Hemodynamics rankings for the second consecutive year.

Home December 28, 2012
Home
Cerebral Angioplasty Stents Radiology Stroke treatment devices
Feature

Some stroke patients may benefit from cerebral angioplasty and stent placement, according to a new study published online in the journal Radiology.

Home December 28, 2012
Home
News

The first patient has been implanted with the Boston Scientific Corporation next generation Ingevity pacing leads in a clinical trial designed to establish the safety, performance and effectiveness of the leads. Pacing leads are insulated wires that connect an implantable pacemaker to the heart for treatment of bradycardia, a condition in which the heart beats too slowly, depriving the body of sufficient oxygen. Pacemakers work in conjunction with leads to sense and stimulate (or pace) the heart, thus maintaining an appropriate heart rate for a given level of physical activity.

Home December 28, 2012
Home
News

Among deployed U.S. service members who died of combat or unintentional injuries between 2001-2011 and underwent autopsies, the prevalence of coronary atherosclerosis was 8.5 percent, with factors associated with a higher prevalence of the disease including older age, lower educational level and prior diagnoses of dyslipidemia, hypertension and obesity, according to a clinical study in the Dec. 26 issue of JAMA.

Home December 28, 2012
Home
News

Pulse Oximetry Screening is a life-saving test that can detect critical congenital heart defects (CCHD) in newborn babies before an infant is discharged from the hospital. The test is easy to perform, however, appropriate interpretation of the results can be challenging. In order to aid health care providers in interpreting the results of the screening, Children's Healthcare of Atlanta has created the Pulse Ox Tool, a ground-breaking app for smart phones that automates the Pulse Oximetry Screening test and improves the accuracy of detecting children with possible CCHD.

Home December 28, 2012
Home
Subscribe Now